Current Environment: Production

John Kennedy | Medical Services

Programs & Services

Languages

  • English

John Kennedy | Education

Undergraduate School

Salisbury University

1999, Salisbury, MD

Graduate School

Trinity College Dublin

2003, Dublin, Ireland

Medical School

University of New Mexico

2010, Albuquerque, NM

Residency

Internal Medicine and Pediatrics

University of Rochester

2014, Rochester, NY

Fellowship

Pulmonary and Critical Care Medicine

Brigham and Women's Hospital

2017, Boston, MA

John Kennedy | Certifications

  • American Board of Internal Medicine (Critical Care Medicine)
  • American Board of Internal Medicine (General)
  • American Board of Internal Medicine (Pulmonary Disease)

John Kennedy | Publications

  1. A progranulin variant causing childhood interstitial lung disease responsive to anti-TNF-a biologic therapy. Med. 2025 Feb 25; 100607. View A progranulin variant causing childhood interstitial lung disease responsive to anti-TNF-a biologic therapy. Abstract

  2. Processes and outcomes from a clinical genetics e-consultation service managed by a primary care physician champion. Genetics in Medicine Open. 2024; 2. View Processes and outcomes from a clinical genetics e-consultation service managed by a primary care physician champion Abstract

  3. Processes and outcomes from a clinical genetics e-consultation service managed by a primary care physician champion. Genet Med Open. 2024; 2:101831. View Processes and outcomes from a clinical genetics e-consultation service managed by a primary care physician champion. Abstract

  4. Limited Effect of Prevention Strategies on Incidence of Clinically Detectable Venous Thromboembolism After Lung Transplantation. Transplant Proc. 2023 Nov; 55(9):2191-2196. View Limited Effect of Prevention Strategies on Incidence of Clinically Detectable Venous Thromboembolism After Lung Transplantation. Abstract

  5. An intronic variant in TBX4 in a single family with variable and severe pulmonary manifestations. NPJ Genom Med. 2023 Mar 06; 8(1):7. View An intronic variant in TBX4 in a single family with variable and severe pulmonary manifestations. Abstract

  6. The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosis. J Cyst Fibros. 2022 03; 21(2):258-263. View The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosis. Abstract

  7. 1-year outcomes for lung transplantation recipients with non-alcoholic fatty liver disease. ERJ Open Res. 2021 Jul; 7(3). View 1-year outcomes for lung transplantation recipients with non-alcoholic fatty liver disease. Abstract

  8. A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findings. PLoS Genet. 2021 07; 17(7):e1009639. View A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findings. Abstract

  9. Alemtuzumab as a Therapy for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With Short Telomeres. Front Immunol. 2020; 11:1063. View Alemtuzumab as a Therapy for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With Short Telomeres. Abstract

  10. New Developments in the Pathogenesis of Pulmonary Cysts in Birt-Hogg-Dubé Syndrome. Semin Respir Crit Care Med. 2020 04; 41(2):247-255. View New Developments in the Pathogenesis of Pulmonary Cysts in Birt-Hogg-Dubé Syndrome. Abstract

  11. Mesenchymal folliculin is required for alveolar development: implications for cystic lung disease in Birt-Hogg-Dubé syndrome. Thorax. 2020 06; 75(6):486-493. View Mesenchymal folliculin is required for alveolar development: implications for cystic lung disease in Birt-Hogg-Dubé syndrome. Abstract

  12. Utility of Comprehensive Assessment for Hepatic Fibrosis in Lung Transplant Candidates. J Heart Lung Transplant. 2020 Apr; 39(4S):S311-S312. View Utility of Comprehensive Assessment for Hepatic Fibrosis in Lung Transplant Candidates. Abstract

  13. Loss of FLCN inhibits canonical WNT signaling via TFE3. Hum Mol Genet. 2019 10 01; 28(19):3270-3281. View Loss of FLCN inhibits canonical WNT signaling via TFE3. Abstract

  14. Mechanisms of pulmonary cyst pathogenesis in Birt-Hogg-Dube syndrome: The stretch hypothesis. Semin Cell Dev Biol. 2016 Apr; 52:47-52. View Mechanisms of pulmonary cyst pathogenesis in Birt-Hogg-Dube syndrome: The stretch hypothesis. Abstract

  15. A 14-Year-Old Boy With Mycoplasma pneumoniae-Associated Mucositis and Intracranial Hypertension. Clin Pediatr (Phila). 2016 Jan; 55(1):83-5. View A 14-Year-Old Boy With Mycoplasma pneumoniae-Associated Mucositis and Intracranial Hypertension. Abstract

  16. Improved quantitative analysis of primary bone marrow megakaryocytes utilizing imaging flow cytometry. Cytometry A. 2014 Apr; 85(4):302-12. View Improved quantitative analysis of primary bone marrow megakaryocytes utilizing imaging flow cytometry. Abstract

  17. Chaperone-mediated autophagy is defective in mucolipidosis type IV. J Cell Physiol. 2009 May; 219(2):344-53. View Chaperone-mediated autophagy is defective in mucolipidosis type IV. Abstract

  18. Mechanism of interferon-gamma-induced increase in T84 intestinal epithelial tight junction. J Interferon Cytokine Res. 2009 Jan; 29(1):45-54. View Mechanism of interferon-gamma-induced increase in T84 intestinal epithelial tight junction. Abstract

  19. Cellular and molecular mechanisms of heat stress-induced up-regulation of occludin protein expression: regulatory role of heat shock factor-1. Am J Pathol. 2008 Mar; 172(3):659-70. View Cellular and molecular mechanisms of heat stress-induced up-regulation of occludin protein expression: regulatory role of heat shock factor-1. Abstract

  20. Etiology of decreased gastric nitric oxide in the critically ill. J Investig Med. 2006 Dec; 54(8):484-9. View Etiology of decreased gastric nitric oxide in the critically ill. Abstract

  21. Mechanism of glucocorticoid regulation of the intestinal tight junction barrier. Am J Physiol Gastrointest Liver Physiol. 2007 Feb; 292(2):G590-8. View Mechanism of glucocorticoid regulation of the intestinal tight junction barrier. Abstract

  22. Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition. Biol Psychiatry. 2003 Dec 15; 54(12):1376-81. View Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition. Abstract

  23. Cloning and characterization of the mouse Mcoln1 gene reveals an alternatively spliced transcript not seen in humans. BMC Genomics. 2002; 3:3. View Cloning and characterization of the mouse Mcoln1 gene reveals an alternatively spliced transcript not seen in humans. Abstract

  24. A physical and transcript map of the MCOLN1 gene region on human chromosome 19p13.3-p13.2. Genomics. 2001 Apr 15; 73(2):203-10. View A physical and transcript map of the MCOLN1 gene region on human chromosome 19p13.3-p13.2. Abstract

  25. Genetic association analysis of behavioral inhibition using candidate loci from mouse models. Am J Med Genet. 2001 Apr 08; 105(3):226-35. View Genetic association analysis of behavioral inhibition using candidate loci from mouse models. Abstract

  26. Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Hum Mol Genet. 2000 Oct 12; 9(17):2471-8. View Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Abstract